Nano-desorption electrospray and kinetic method in chiral analysis of drugs in whole human blood samples

European Journal of Mass Spectrometry

Volumn 14, Issue 6, 2008, Pages 411-417

  Ranc, Václav ^a   Havlíček, Vladimír ^a,b   Bednar, Petr ^a   Lemr, Karel ^a,b  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b INSTITUTE OF MICROBIOLOGY   (Czech Republic)

Author keywords

Chiral analysis; Drug analysis; Human blood samples; Kinetic method; Mass spectrometry; Nano desorption electrospray

Indexed keywords

DOPA; DRUG; EPHEDRINE; IBUPROFEN;

ARTICLE; BLOOD; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; INSTRUMENTATION; KINETICS; METHODOLOGY; NANOTECHNOLOGY; STEREOISOMERISM;

DIHYDROXYPHENYLALANINE; EPHEDRINE; HUMANS; IBUPROFEN; KINETICS; NANOTECHNOLOGY; PHARMACEUTICAL PREPARATIONS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; STEREOISOMERISM;

EID: 60049085305     PISSN: 14690667     EISSN: None     Source Type: Journal    
DOI: 10.1255/ejms.978     Document Type: Article

References (33)

1. A. Gross, "Best practice in therapeutic drug monitoring", Brit. J. Clin. Pharmacol. 46, 95-99 (1998). doi: 10.1046/j.1365-2125.1998.00770.X
2. C. Suthakaran and C. Adithan, "Therapeutic drug monitoring, concepts, methodology, clinical applications and limitations", Health Administrator XIX, 22 (2004).
3. B.D. Kahan, "A therapeutic drug monitoring of cyclosporine: 20 years of progress", Transplant. Proc. 36, S378-S391 (2004). doi: 10.1016/j.transproceed.2004.01.091
4. R. Heeswijk, "Critical issues in therapeutic drug monitoring of antiretroviral drugs", Ther. Drug Monit. 24, 323-331 (2002). doi: 10.1097/00007691-200206000-00001
5. M.J. Eadie, "Therapeutic drug monitoring-antiepileptic drugs", Brit. J. Clin. Pharmacol. 46, 185-193 (1998). doi: 10.1046/j.1365-2125.1998.00769.x
6. S.H.Y. Wong and I. Sunshine, Handbook of Analytical Therapeutic Drug Monitoring and Toxicology. CRC Press, Boca Raton, Florida, USA (1996).
7. H.H. Maurer, "Liquid chromatography-mass spectrometry in forensic and clinical toxicology", J. Chromatogr. B 713, 3-25 (1998). doi: 10.1016/S0378-4347(97)00514-8
8. M. Thevis, A. Thomas, P. Delahaut, A. Bosseloir and W. Schänzer, "Doping control analysis of intact rapid-acting insulin analogues in human urine by liquid chromatography-tandem mass spectrometry", Anal. Chem. 78, 1897-1903 (2006). doi: 10.1021/ac052095z
9. Z. Takáts, B. Gologan, J.M. Wiseman and R.G. Cooks, "Method and system for desorption electrospray ionization", US Patent 7,335,897, P1452, (2008).
10. R.G. Cooks, Z. Ouyang, Z. Takats and J.M. Wiseman, "Ambient mass spectrometry", Science 311, 1566-1570 (2006). doi: 10.1126/science.1119426
11. T.J. Kauppila, J.M. Wiseman, R.A. Ketola, T. Kotiaho, R.G. Cooks and R. Kostiainen, "Desorption electrospray ionization mass spectrometry for the analysis of pharmaceuticals and metabolites", Rapid Commun. Mass Spectrom. 20, 387-392 (2006). doi: 10.1002/rcm.2304
12. Z. Takats, J.M. Wiseman and R.G. Cooks, "Ambient mass spectrometry using desorption electrospray ionization (DESI): instrumentation, mechanisms and applications in forensics, chemistry, and biology", J. Mass Spectrom. 40, 1261-1275 (2005). doi: 10.1002/jms.922
13. Z. Takats, J.M. Wiseman, B. Gologan and R.G. Cooks, "Mass spectrometry sampling under ambient conditions with desorption electrospray ionization", Science 306, 471-473 (2004). doi: 10.1126/science.1104404
14. J.P. Williams and J.H. Scrivens, "Rapid accurate mass desorption electrospray ionisation tandem mass spectrometry of pharmaceutical samples", Rapid Commun. Mass Spectrom. 19, 3643-3650 (2005). doi: 10.1002/rcm.2251
15. H. Chen, N.N. Talaty, Z. Takats and R.G. Cooks, "Desorption electrospray ionization mass spectrometry for high-throughput analysis of pharmaceutical samples in the ambient environment", Anal. Chem. 77, 6915-6927 (2005). doi: 10.1021/ac050989d
16. J.M. Wiseman, D.R. Ifab, Y. Zhu, C.B. Kissinger, N.E. Manicke, P.T. Kissinger and R.G. Cooks, "Desorption electrospray ionization mass spectrometry: Imaging drugs and metabolites in tissues", Proc. Natl. Acad. Sci. USA 105, 18120-18125 (2008). doi: 10.1073/pnas.0801066105
17. T.J. Kauppila, N. Talaty, T. Kuuranne, T. Kotiaho, R. Kostiainen and R.G. Cooks, "Rapid analysis of metabolites and drugs of abuse from urine samples by desorption electrospray ionization-mass spectrometry", Analyst 132, 868-875 (2007). doi: 10.1039/b703524a
18. G. Huang, H. Chen, X. Zhang, R.G. Cooks and Z. Ouyang, "Rapid screening of anabolic steroids in urine by reactive desorption electrospray ionization", Anal. Chem. 79, 8327-8332 (2007). doi: 10.1021/ac0711079
19. L.A. Leuthold, J.-F. Mandscheff, M. Fathi, C. Giroud, M. Augsburger, E. Varesio and G. Hopfgartner, "Desorption electrospray ionization mass spectrometry: direct toxicological screening and analysis of illicit ecstasy tablets", Rapid Commun. Mass Spectrom. 20, 103-110 (2006). doi: 10.1002/rcm.2280
20. V. Ranc, V. Havlicek, P. Bednarand K. Lemr, "Desorption electrospray: A modern tool for organic surface analysis", Chem. Listy 101, 524-529 (2007).
21. W.A. Tao, D. Zhang, F. Wang, P.D. Thomas and R.G. Cooks, "Kinetic resolution of D,L-amino acids based on gas-phase dissociation of copper(II) complexes", Anal. Chem. 71, 4427-4429 (1999). doi: 10.1021/ac990530h
22. W.A. Tao, D. Zhang, E.N. Nikolaev and R.G. Cooks, "Copper(II)- assisted enantiomeric analysis of D,L-amino acids using the kinetic method: Chiral recognition and quantification in the gas phase", J. Am. Chem. Soc. 122, 10598-10609 (2000). doi: 10.1021/ja000127o
23. W.A. Tao, F.C. Gozzo and R.G. Cooks, "Mass spectrometric quantitation of chiral drugs by the kinetic method". Anal. Chem. 73, 1692-1698 (2001). doi: 10.1021/ac001150v
24. D. Zhang, W.A. Tao and R.G. Cooks, "Chiral resolution of D- and L-amino acids by tandem mass spectrometry of Ni(II)-bound trimeric complexes", Int. J. Mass Spectrom. 204, 159-169 (2001). doi: 10.1016/S1387-3806(00)00330-4
25. W.A. Tao and R.G. Cooks, "Chiral analysis by MS", Anal. Chem. 75, 25A-31A (2003). doi: 10.1021/ac0312110
26. Compendium of Pharmaceuticals and Specialties 2008. The Canadian Drug Reference for Health Professionals, Canadian Pharmaceutical Assn., Canada (2007).
27. M.A. Hamman, G.A. Thompson and S.D. Hall, "Regioselective and stereoselective metabolism of ibuprofen by human cytochrome P450 2C", Biochem. Pharmacol. 54, 33-41 (1997). doi: 10.1016/S0006-2952(97) 00143-3
28. The 2008 prohibited list international standard, The world anti-doping code, World anti-doping agency (2007).
29. D.V. Augusti and R. Augusti, "Determination of the enantiomeric composition of ibuprofen solutions via a rapid and sensitive mass spectrometry method", Tetrahedron-Asymmetry 16, 1881-1885 (2005). doi: 10.1016/j.tetasy.2005.04.005
30. D. Woitalla, "Relevance of plasma level determination of L-DOPA and 3-O-methyldopa in Parkinson's disease", Aktuelle Neurol. 25, S279-S281 (1998). doi: 10.1055/s-2007-1017745
31. J.C. Garriott, L.M. Simmons, A. Poklis and M.A. Mackell, "Five cases of fatal overdose from caffeine-containing look-alike drugs", J. Anal. Toxicol. 9, 141-143 (1985).
32. V. Ranc, V. Havlicek, P. Bednar and K. Lemr, "Magnesium interference in phenylalanine enantiomeric discrimination by the kinetic method", Int. J. Mass Spectrom., in press (2008). doi: 10.1016/j.ijms.2008.09.009
33. E.M. Laska, A. Sunshine, I. Merrero, N. Olson, C. Siegel and N. McCormick, "The correlation between blood-levels of ibuprofen and clinical analgesic response", Clin. Pharmacol. Ther. 40, 1-7 (1986).